Literature DB >> 15883711

Paragangliomas of the head and neck: diagnosis and treatment.

C C Boedeker1, G J Ridder, J Schipper.   

Abstract

Paragangliomas of the head and neck (HNP) represent rare tumors of neural crest origin. They are highly vascular neoplasms that are benign in the majority of cases. The site of origin defines the name given those tumors. In the head and neck, they most commonly occur at the carotid bifurcation, where they are referred to as carotid body tumors (CBT). Other common sites of origin are the jugular bulb (jugular paraganglioma; JP), the tympanic plexus on the promontory (tympanic paraganglioma; TP) and the vagal nerve (vagal paraganglioma; VP). Patients with cervical paragangliomas frequently present with a painless, slowly enlarging mass in the lateral neck. In many patients with TP and JP, tinnitus and hearing loss are early symptoms. JP patients often suffer from lower cranial nerve deficits. Evaluation by an imaging modality is necessary to establish the diagnosis. Imaging procedures frequently used include B-mode sonography with color-coded Doppler sonography, computed tomography (CT), magnetic resonance imaging (MRI) and digital substraction angiography (DSA). Debate exists in the literature regarding the different treatment modalities for paragangliomas which include surgery, radiotherapy and stereotactic radiosurgery. The role of preoperative angiography and embolization has also been a matter of discussion. The diagnostic work up and the different treatment options for patients with head and neck paragangliomas will be presented and discussed.

Entities:  

Mesh:

Year:  2005        PMID: 15883711     DOI: 10.1007/s10689-004-2154-z

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  22 in total

1.  Preoperative embolization of carotid body tumors: when is it appropriate?

Authors:  V R Litle; L M Reilly; T K Ramos
Journal:  Ann Vasc Surg       Date:  1996-09       Impact factor: 1.466

2.  Vagal paraganglioma: the Jefferson experience.

Authors:  R B Miller; M S Boon; J P Atkins; L D Lowry
Journal:  Otolaryngol Head Neck Surg       Date:  2000-04       Impact factor: 3.497

3.  Definitive radiotherapy in the management of chemodectomas arising in the temporal bone, carotid body, and glomus vagale.

Authors:  R W Hinerman; W M Mendenhall; R J Amdur; S P Stringer; P J Antonelli; N J Cassisi
Journal:  Head Neck       Date:  2001-05       Impact factor: 3.147

4.  Glomus vagale tumors.

Authors:  H F Biller; W Lawson; P Som; R Rosenfeld
Journal:  Ann Otol Rhinol Laryngol       Date:  1989-01       Impact factor: 1.547

5.  Management of carotid body paragangliomas and review of a 30-year experience.

Authors:  Peter Patetsios; Dennis R Gable; Wilson V Garrett; Jeffrey P Lamont; Joseph A Kuhn; William P Shutze; Harry Kourlis; Bradley Grimsley; Gregory J Pearl; Bertram L Smith; C M Talkington; Jesse E Thompson
Journal:  Ann Vasc Surg       Date:  2002-04-18       Impact factor: 1.466

6.  Radiation therapy for paragangliomas of the temporal bone.

Authors:  J O Boyle; D S Shimm; S W Coulthard
Journal:  Laryngoscope       Date:  1990-08       Impact factor: 3.325

7.  Surgical management of carotid body tumors.

Authors:  S J Wang; M B Wang; T M Barauskas; T C Calcaterra
Journal:  Otolaryngol Head Neck Surg       Date:  2000-09       Impact factor: 3.497

8.  Paraganglioma as a systemic syndrome: pitfalls and strategies.

Authors:  W Maier; N Marangos; R Laszig
Journal:  J Laryngol Otol       Date:  1999-11       Impact factor: 1.469

9.  Glomus jugulare tumor: tumor control and complications after stereotactic radiosurgery.

Authors:  Robert L Foote; Bruce E Pollock; Deborah A Gorman; Paula J Schomberg; Scott L Stafford; Michael J Link; Robert W Kline; Scott E Strome; Jan L Kasperbauer; Kerry D Olsen
Journal:  Head Neck       Date:  2002-04       Impact factor: 3.147

10.  Radiosurgery for paraganglioma of the temporal bone.

Authors:  Steven J Feigenberg; William M Mendenhall; Russell W Hinerman; Robert J Amdur; William A Friedman; Patrick J Antonelli
Journal:  Head Neck       Date:  2002-04       Impact factor: 3.147

View more
  36 in total

1.  Head and neck pathology-radiology classics: vagal paraganglioma.

Authors:  Edina Paal; Ellen M Chung
Journal:  Head Neck Pathol       Date:  2007-11-27

2.  [A young patient with paraganglioma syndrome type I. An interdisciplinary challenge].

Authors:  C Brase; H Neumann; M Lell; S Schwarz-Furlan; K Rogler; J Hornung
Journal:  HNO       Date:  2012-08       Impact factor: 1.284

3.  Paragangliomas of the Head & Neck: the KMC experience.

Authors:  Sampath Chandra Prasad; Nikhil Thada; Kishore Chandra Prasad
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-01-21

Review 4.  Paragangliomas of the head and neck.

Authors:  Michael E Kupferman; Ehab Y Hanna
Journal:  Curr Oncol Rep       Date:  2008-03       Impact factor: 5.075

5.  Clinical features of paraganglioma syndromes.

Authors:  Carsten Christof Boedeker; Hartmut P H Neumann; Christian Offergeld; Wolfgang Maier; Maurizio Falcioni; Ansgar Berlis; Joerg Schipper
Journal:  Skull Base       Date:  2009-01

6.  Evolving concepts in the management of jugular paraganglioma: a comparison of radiotherapy and surgery in 88 cases.

Authors:  Patrice Tran Ba Huy; Romain Kania; Michèle Duet; Bernadette Dessard-Diana; Jean-Jacques Mazeron; Rania Benhamed
Journal:  Skull Base       Date:  2009-01

7.  Paraganglioma neck − a neuroendocrine tumour revisited.

Authors:  Arcot Rekha; Annamalai Ravi; Ks Vijayaraghavan
Journal:  Int J Angiol       Date:  2008

Review 8.  ⁶⁸Ga-labelled peptides in the management of neuroectodermal tumours.

Authors:  Meeran Naji; Adil AL-Nahhas
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-02       Impact factor: 9.236

9.  Diagnosis and management of hereditary paraganglioma syndrome due to the F933>X67 SDHD mutation.

Authors:  Monica L Marvin; Carol R Bradford; James C Sisson; Stephen B Gruber
Journal:  Head Neck       Date:  2009-05       Impact factor: 3.147

10.  Carotid Body Tumor Microenvironment.

Authors:  Jean-Paul Bryant; Shelly Wang; Toba Niazi
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.